Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial [Phase 2]
Phase II open-label study evaluating PD-1 inhibitors plus chemoradiotherapy in metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: GNT Induction Treatment in Locally Advanced NPC [Phase 3]
Phase 3 trial update for GNT induction treatment in locally advanced nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) [Phase 1, Phase 2]
Phase 1/2a study of VK-2019 in EBV-positive nasopharyngeal carcinoma was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Anrotinib and Tirelizumab in First-line Treatment of RM-NPC [Phase 2]
Phase 2 clinical trial exploring anrotinib and tirelizumab as first-line treatment for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating multiple-dose JS004 in head and neck cancers, assessing safety and efficacy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients [Phase 2]
Phase II trial investigating neoadjuvant and adjuvant toripalimab with concurrent chemoradiotherapy in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients [Phase 3]
A Phase III trial evaluating chemotherapy and immunotherapy for advanced nasopharyngeal carcinoma has completed recruitment with results pos…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase II study evaluating Epstein-Barr virus–specific immunotherapy for nasopharyngeal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial updating chemoradiation regimens using cisplatin- or carboplatin-based therapy for locoregionally advanced nasopharyngeal carc…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating camrelizumab after radiotherapy in patients with oligometastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) [Phase 2]
Phase 2 trial investigating Epstein-Barr virus DNA response to systemic therapy for treatment adaptation in high-risk nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating reduced-target resection after induction chemotherapy in resectable recurrent nasopharyngeal carcinoma i…
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial comparing TPF+CCRT versus CCRT+PF for high-risk nasopharyngeal carcinoma is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma [Phase 3]
Phase III trial update for adjuvant chemotherapy in nasopharyngeal carcinoma (N2-3) is in progress with unknown status.
-
CLINICAL_TRIALS research · 2023-05-16Clinical Trial Update: Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 clinical trial is comparing two cycles versus three cycles of induction chemotherapy for locally advanced nasopharyngeal carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC [Phase 3]
Phase 3 trial comparing gemcitabine and camrelizumab plus apatinib vs cisplatin as first-line therapy for nasopharyngeal carcinoma is ongoin…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure [Phase 2]
Phase 2 trial evaluating apatinib combined with camrelizumab in recurrent or metastatic nasopharyngeal carcinoma after first-line treatment …
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating induction chemotherapy followed by IMRT versus concurrent chemoradiotherapy in locoregionally advanced nasopharynge…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating PD-1 blockade combined with intensity-modulated radiation therapy for intermediate-risk nasopharyngeal carcinoma; c…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing TPC versus PF as induction chemotherapy combined with concurrent chemoradiotherapy for stage IVa-b nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Cadonilimab (AK104) in the Treatment of Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update for Cadonilimab (AK104) in nasopharyngeal carcinoma; status not reported in the provided snippet.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating camrelizumab for locally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC [Phase 3]
A Phase 3 randomized trial comparing Leucogen to placebo for management of leukocyte and platelet counts during PFLL chemotherapy in stage I…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy [Phase 3]
A Phase 3 trial evaluating intensified treatments for locally advanced nasopharyngeal carcinoma with detectable EBV DNA after one cycle of G…
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study [Phase 2]
Phase II open-label study evaluating the efficacy and safety of sintilimab plus bevacizumab in patients with metastatic nasopharyngeal carci…